Global Cord Blood Corporation (CO) Misses Q1 EPS by 4c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2019
August 23, 2018 4:16 PM EDT1Q19 Added 20,601 New Subscribers Revenues Increased to RMB233.8 Million ($35.3 Million)Operating Income Up 15.0% YoY to RMB95.4 Million ($14.4 Million)Non-GAAP Operating Income Up 17.7% YoY to RMB108.6 Million ($16.4 Million)Conference Call to be Held on August 24, 2018 at 8:00 a.m. ET
HONG KONG, Aug. 23, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the first quarter of fiscal 2019... More
